0.25 mg weekly
The label calls this a starting dose; it is not meant for blood sugar control on its own.
Ozempic® is the brand name for semaglutide, a GLP-1 receptor agonist approved for adults with type 2 diabetes. It lowers blood sugar and slows gastric emptying. It is not FDA-approved for weight management; the semaglutide brand approved for weight is Wegovy®.
The curve illustrates the general shape of GLP-1 weight loss against diet alone, not an Ozempic result. Ozempic was trialed for blood sugar, heart and kidney outcomes, so this page shows no weight-loss bar for it.
This is the Ozempic label schedule. Steps after 0.5 mg happen only if more blood sugar control is needed, and your provider decides.
The label calls this a starting dose; it is not meant for blood sugar control on its own.
The first treatment dose.
After at least 4 weeks on 0.5 mg, if more control is needed.
After at least 4 weeks on 1 mg. 2 mg weekly is the label maximum.
Quick health questionnaire — about 5 minutes. We use it to match you to the right medication and dose.
A US-licensed clinician reviews your full profile and either prescribes or comes back with a question.
Your medication arrives free of charge with everything you need to start. Provider support is included.
All three contain semaglutide. Ozempic is labeled for type 2 diabetes, up to 2 mg weekly. Wegovy is the Novo Nordisk semaglutide labeled for weight reduction, up to 2.4 mg weekly as an injection or 25 mg daily as a tablet. Compounded semaglutide is made by a licensed pharmacy and is not FDA-approved.
If your goal is weight loss without diabetes, ask your provider about compounded semaglutide, which Gala offers from $69 a month on the annual plan.
Your provider reviews your diagnosis, current medicines and history, including any thyroid cancer history or pregnancy plans, against the Ozempic label. If Ozempic fits, it is prescribed as brand-name pens and dosed on the label schedule. If your main goal is weight and you do not have type 2 diabetes, your provider will usually point you to a semaglutide option meant for weight instead.
Ozempic carries a boxed warning about thyroid C-cell tumors. The most common side effects are nausea, vomiting, diarrhea, abdominal pain and constipation. The label says to stop Ozempic at least 2 months before a planned pregnancy. A Gala provider reviews these points with your history before prescribing.
The active molecule is the same. Ozempic® is FDA-approved and manufactured by Novo Nordisk. Compounded semaglutide is prepared by licensed compounding pharmacies, is not FDA-approved, and costs much less at Gala.
Ozempic® is FDA-approved for type 2 diabetes, not for weight management. Wegovy® is the semaglutide brand approved for weight reduction. A Gala provider reviews your history and decides which semaglutide option, if any, fits you.
Both are Novo Nordisk semaglutide. Ozempic® is labeled for type 2 diabetes with doses up to 2 mg weekly. Wegovy® is labeled for weight reduction and heart risk reduction, up to 2.4 mg weekly by injection or as a daily tablet. Ozempic vs Wegovy
The label starts at 0.25 mg once weekly for 4 weeks, then 0.5 mg. If more blood sugar control is needed, the dose can go to 1 mg and then 2 mg, each after at least 4 weeks on the previous dose. GLP-1 dosing schedule
Gala is cash-pay and does not bill insurance. Some insurance plans cover Ozempic® for type 2 diabetes through a local pharmacy; coverage for weight loss alone is uncommon.
This page is general information, not medical advice. A licensed provider decides whether a treatment is right for you.